HGP Advises Medisolv in Acquisition of Lilac Software

March 10, 2026

Medisolv, Inc., a national leader in healthcare quality data management, today announced the acquisition of Lilac Software, Inc., an innovator in AI-driven predictive analytics and Medicare Advantage Stars performance. This acquisition represents a strategic expansion of Medisolv’s capabilities into predictive, AI-powered quality intelligence designed to help healthcare organizations navigate increasingly complex value-based care models.

With the addition of Lilac, Medisolv expands its capabilities to include claims-based quality measurement, HEDIS performance analytics, and predictive insights that help organizations identify risk earlier and improve performance under value-based reimbursement models.

Beyond these CMS programs, the technology will help healthcare organizations identify and address gaps in care through scalable patient outreach and predictive analytics. Connecting provider clinical data with payer claims-based insights will give healthcare organizations a more complete view of quality performance while reducing the administrative burden of quality reporting.

To read more, visit the press release here.

Recent Research & News

HGP Advises Alora in sale to Livtech

HGP Advises Medisolv in Acquisition of Lilac Software

AI trends shaping the Health IT Transaction Landscape